Takeda Pharmaceutical CEO Christophe Weber

Christophe Weber, president and CEO of Takeda Pharmaceutical Co., speaks in Osaka on May 28, 2019. The Japanese company will build a new facility to ramp up production of an anticancer drug at its plant in Osaka. (Kyodo) ==Kyodo

Sample
PDF Preview

Product Code
ILEA000159583

Registered date
2019/5/28 18:15:34

Credit
Kyodo / Kyodo News Images

Media source
2019 Kyodo News

Media size
2605 × 3968 pixel

Resolution
240 dpi

Deployment size
773.70(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Daihatsu unveils new management policy after testing scandal

TOKYO, Japan, April 8 Kyodo - Daihatsu Motor Co. President Masahiro Inoue attends a press conference in Tokyo on April 8, 2024, as the company releases a new management policy following a scandal over improper safety testing. Daihatsu said its parent company Toyota Motor Corp. will be in charge of development and safety approval for some of the models Daihatsu had handled while it will focus on its mainstay minivehicle business. (Kyodo)

Daihatsu unveils new management policy after testing scandal

Daihatsu Motor Co. President Masahiro Inoue attends a press conference in Tokyo on April 8, 2024, as the company releases a new management policy following a scandal over improper safety testing. Daihatsu said its parent company Toyota Motor Corp. will be in charge of development and safety approval for some of the models Daihatsu had handled while it will focus on its mainstay minivehicle business. ==Kyodo

New whaling factory ship

Hideki Tokoro, president of commercial whaling operator Kyodo Senpaku Co., meets the press in Shimonoseki, western Japan, on March 29, 2024, after Kangei Maru, the world's only whaling factory ship, was delivered to his company earlier in the day, following the retirement of its predecessor, Nisshin Maru, in November 2023.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi speaks at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (2nd from L) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (C) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (R) apologizes at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharma headquarters in Osaka

Photo taken from a Kyodo News helicopter on March 28, 2024, shows the building that houses Kobayashi Pharmaceutical Co.'s headquarters in the western Japan city of Osaka.

Kobayashi Pharma shareholders' meeting in Osaka

A Kobayashi Pharmaceutical Co. shareholder (R) speaks to reporters ahead of the company's annual shareholders' meeting in the western Japan city of Osaka on March 28, 2024. The company said it has confirmed two more deaths linked to the consumption of its red yeast rice dietary supplements which had already been implicated in two other deaths from kidney-related conditions and over 100 hospitalizations.

Nissan, Honda eye EV tie-up

TOKYO, Japan, March 15 Kyodo - Nissan Motor Co. President Makoto Uchida (L) and Honda Motor Co. President Toshihiro Mibe attend a press conference on a feasibility study by the automakers for a strategic partnership in electric vehicle production and other advanced technologies in Tokyo on March 15, 2024. (Kyodo)